Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers
Pathogens · 2025
DOI: 10.3390/pathogens14111186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Aysun Benli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Istanbul Faculty of Medicine, University of Istanbul, Istanbul 34093, Turkey. Hauptthemen laut MEDLINE: Brucellosis, Agglutination Tests. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study was designed to determine the differences between brucellosis patients whose standard tube agglutination test (SAT) titers decreased or not after successful treatment.
Methods
This retrospective study included patients with a course of antibiotic therapy at least 6 weeks for acute brucellosis or 12 weeks for osteoarticular involvement, and whose post-treatment clinical findings improved.
Results
The mean age of the 276 patients was 45.2 years, and 50.7% were female. The SAT titer decreased in 166 patients (60%). No significant differences were found in terms of demographical and epidemiological characteristics between the groups. Patients with decreased SAT titers exhibited an elevated pre-treatment erythrocyte sedimentation rate (ESR) and the lymphocytosis was more prevalent. In the non-decreased SAT group, liver enzymes such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) values after treatment were higher. The initial SAT titer of 1/160 and the pre-treatment rates of anaemia and thrombocytopenia were significantly higher in patients whose SAT titers became negative. Among patients whose SAT titers remained positive, the initial SAT titer was more frequently ≥1/320, and the post-treatment AST value was higher.
Conclusions
This study showed that a serological response can be obtained with a high ESR and lymphocytosis prior to treatment. It should be noted that SAT negativity cannot be observed immediately in patients with pre-treatment SAT titers ≥ 1/320. The healthcare providers are advised to consider the complete clinical picture without relying solely on serological results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Istanbul Faculty of Medicine, University of Istanbul, Istanbul 34093, Turkey.
- Department of Medical Microbiology, Basaksehir Çam and Sakura City Hospital, University of Health Science, Istanbul 34480, Turkey.
ORCID-Profile: Aysun Benli, Ayşe Nur Ceylan
Zitieren
APA
Benli, A., & Ceylan, A. N. (2025). Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers. Pathogens. https://doi.org/10.3390/pathogens14111186
Vancouver
Benli A, Ceylan AN. Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers. Pathogens. 2025. doi:10.3390/pathogens14111186
BibTeX
@article{Benli2025,
author = {Benli, Aysun and Ceylan, Ayşe Nur},
title = {Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14111186}
}
EUVIMED